Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DAO | P14920 | 1/20 | 0.38 |
| ▸ | GABRA1 | P14867 | 3/20 | 0.36 |
| ▸ | GABRB2 | P47870 | 3/20 | 0.36 |
| ▸ | HTR1A | P08908 | 1/20 | 0.36 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.34 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.34 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.34 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.34 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.34 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.33 |
| ▸ | AR | P10275 | 1/20 | 0.33 |
| ▸ | PPARG | P37231 | 1/20 | 0.33 |
| ▸ | PPARA | Q07869 | 1/20 | 0.33 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.33 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.33 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2119420 | 0.88 | CYP3A4 (0.44) | CYP2D6CYP2C9CYP2C19LIPGPPARG | |
| SCHEMBL1584216 | 0.86 | LIPG (0.50) | LIPGPPARGPPARA | |
| SCHEMBL10708843 | 0.84 | LIPG (0.53) | LIPGPPARGPPARA | |
| SCHEMBL2121348 | 0.84 | LIPG (0.53) | LIPGPPARGPPARA | |
| SCHEMBL10473131 | 0.84 | LIPG (0.53) | LIPGPPARGPPARA | |
| SCHEMBL6222240 | 0.84 | LIPG (0.53) | LIPGPPARGPPARA | |
| SCHEMBL2119800 | 0.84 | LIPG (0.53) | LIPGPPARGPPARA | |
| SCHEMBL535892 | 0.84 | GABRA1 (0.45) | GABRA1GABRB2FFAR1CYP2D6MAPT | |
| SCHEMBL1141480 | 0.82 | HTR1A (0.38) | DAOGABRA1GABRB2HTR1AFFAR1 | |
| SCHEMBL9744164 | 0.78 | TDP1 (0.39) | FFAR1CYP1A2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 171 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114681473-A | Application of glucosamine and derivatives thereof as anti-novel coronavirus drugs | 南湖实验室 | 2022-07-01 | — | — | CN | claimed |
| CN-112336733-A | Application of glucosamine and derivatives thereof as anti-novel coronavirus drugs | 南湖实验室 | 2021-02-09 | — | — | CN | claimed |
| EP-1937622-A1 | COMPOUNDS FOR TREATMENT OF LIPASE-MEDIATED DISEASES | Reliance Life Sciences Pvt., Ltd. (IN) | 2008-07-02 | — | — | EP | claimed |
| US-20070054958-A1 | Compounds for treatment of lipase-mediated diseases | RELIANCE LIFE SCIENCES PVT. LTD. (IN) | 2007-03-08 | — | — | US | claimed |
| WO-2007010546-A1 | COMPOUNDS FOR TREATMENT OF LIPASE-MEDIATED DISEASES | RELIANCE LIFE SCIENCES PVT LTD (IN) | 2007-01-25 | — | — | WO | claimed |
| EP-0599819-B1 | Use of hydroxycarboxylic acids and derivatives for the preparation of topical dermatologic compositions for the treatment of wrinkles | SCOTT EUGENE J VAN (US) | 1997-04-02 | — | — | EP | claimed |
| US-4994468-A | Bronchodilators, antiallergens | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1991-02-19 | — | — | US | claimed |
| CN-117860712-A | Ammonia sugar composition for inhalation, preparation method and application thereof | 中国人民解放军军事科学院军事医学研究院 | 2024-04-12 | — | — | CN | disclosed |
| WO-2024024760-A1 | PYRAZOLONE COMPOUND AND PYRAZOLONE AGENT | 公益財団法人野口研究所 | 2024-02-01 | — | — | WO | disclosed |
| CN-114732822-A | Application of glucosamine and derivatives thereof as antiviral drugs | 中国人民解放军军事科学院军事医学研究院 | 2022-07-12 | — | — | CN | disclosed |
| CN-114732823-A | Application of glucosamine and derivatives thereof as antiviral drugs | 中国人民解放军军事科学院军事医学研究院 | 2022-07-12 | — | — | CN | disclosed |
| CN-114681473-A | Application of glucosamine and derivatives thereof as anti-novel coronavirus drugs | 南湖实验室 | 2022-07-01 | — | — | CN | disclosed |
| CN-114681472-A | Application of glucosamine and derivatives thereof as antiviral drugs | 中国人民解放军军事科学院军事医学研究院 | 2022-07-01 | — | — | CN | disclosed |
| EP-0386722-A1 | Imidazoquinolone derivatives | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1990-09-12 | — | — | EP | disclosed |
| EP-0330241-A2 | Calcitonin derivatives | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1989-08-30 | — | — | EP | disclosed |
| US-4753951-A | ANTIDEPRESSANTS, ANXIOLYTICS | SHIONOGI & CO., LTD. (JP) | 1988-06-28 | — | — | US | disclosed |
| EP-0223420-A1 | Condensed imidazopyridine derivatives | SHIONOGI & CO., LTD. (JP) | 1987-05-27 | — | — | EP | disclosed |
| US-4438277-A | Hydronaphthalene derivatives | SANKYO COMPANY, LIMITED (JP) | 1984-03-20 | — | — | US | disclosed |
| US-4361515-A | Antihyperlipemic dihydro-ML-236B derivatives, their preparation and use | SANKYO COMPANY, LIMITED (JP) | 1982-11-30 | — | — | US | disclosed |
| US-4255151-A | ANTHRAQUINONE DYES, SWELLING, HEAT FIXING | BAYER AKTIENGESELLSCHAFT (DE) | 1981-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070054958-A1 | Compounds for treatment of lipase-mediated diseases | LIPE, LIPG, LPL | DAO 1175/4885GABRA1 4257/4885GABRB2 3956/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.